S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:MIRA

MIRA Pharmaceuticals (MIRA) Stock Forecast, Price & News

$4.49
+0.08 (+1.81%)
(As of 09/25/2023 ET)
Today's Range
$4.42
$5.21
50-Day Range
N/A
52-Week Range
$3.00
$7.98
Volume
66,807 shs
Average Volume
137,581 shs
Market Capitalization
$66.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About MIRA Pharmaceuticals

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

MIRA Price History

MIRA Stock News Headlines

George Cappy Mira Pharmaceuticals, Inc
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
See More Headlines
Receive MIRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

MIRA Company Calendar

Today
9/25/2023
Next Earnings (Estimated)
12/15/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
N/A
Current Symbol
NASDAQ:MIRA
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$66.36 million
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Adam Kaplin M.D. (Age 56)
    Ph.D., Co-Founder, Pres & Chief Science Officer
    Comp: $50k
  • Dr. Christopher C. Chapman Jr. (Age 70)
    M.D., Exec. Chairman
  • Mr. Erez Aminov (Age 45)
    CEO & Director
  • Ms. Michelle Yanez M.B.A. (Age 51)
    CFO, Sec. & Treasurer
  • Mr. Christos Nicholoudis Esq. (Age 33)
    Gen. Counsel & Director













MIRA Stock - Frequently Asked Questions

How have MIRA shares performed in 2023?

MIRA Pharmaceuticals' stock was trading at $6.01 at the beginning of 2023. Since then, MIRA stock has decreased by 25.3% and is now trading at $4.49.
View the best growth stocks for 2023 here
.

When is MIRA Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, December 15th 2023.
View our MIRA earnings forecast
.

When did MIRA Pharmaceuticals IPO?

(MIRA) raised $9 million in an initial public offering (IPO) on Thursday, August 3rd 2023. The company issued 1,275,000 shares at a price of $7.00 per share.

What is MIRA Pharmaceuticals' stock symbol?

MIRA Pharmaceuticals trades on the NASDAQ under the ticker symbol "MIRA."

When did the company's quiet period expire?

MIRA Pharmaceuticals' quiet period expired on Tuesday, September 12th. MIRA Pharmaceuticals had issued 1,275,000 shares in its IPO on August 3rd. The total size of the offering was $8,925,000 based on an initial share price of $7.00. During the company's quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of MIRA Pharmaceuticals?

Shares of MIRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MIRA Pharmaceuticals' stock price today?

One share of MIRA stock can currently be purchased for approximately $4.49.

How much money does MIRA Pharmaceuticals make?

MIRA Pharmaceuticals (NASDAQ:MIRA) has a market capitalization of $66.36 million.

How can I contact MIRA Pharmaceuticals?

The official website for the company is mirapharmaceuticals.com. The company can be reached via phone at 737-289-0835.

This page (NASDAQ:MIRA) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -